| 03.12.2025 14:23 | SVNS | Solvonis hails US discovery programme approval for addiction compound | Alliance |
| 03.12.2025 10:25 | ONDO, HAN, SVNS | SMALL-CAP WINNERS & LOSERS: Hansa rises; Ondo InsurTech loss widens | Alliance |
| 03.12.2025 07:00 | SVNS | SVN-015 accepted into US NIDA funded programme | RNS |
| 31.10.2025 15:59 | SVNS | Total Voting Rights | RNS |
| 31.10.2025 07:00 | SVNS | Corporate Structure Update and Issue of Options | RNS |
| 27.10.2025 07:00 | SVNS | Appoints global biopharma leader Paul Carter | RNS |
| 16.10.2025 21:51 | SVNS, BUCE, CHL | TRADING UPDATES: Gelion plans fund raise alongside testing agreement | Alliance |
| 16.10.2025 07:00 | SVNS | Raises £1.25 Million to Accelerate Programmes | RNS |
| 30.09.2025 13:06 | OVB, SVNS, GENF | EARNINGS: GENinCode sees annual revenue growth slower than expected | Alliance |
| 30.09.2025 07:00 | SVNS | Half-year Report | RNS |
| 28.08.2025 11:11 | SVNS, AVG, FDR | TRADING UPDATES: Avingtrans HS2 win; Metals Exploration's Runruno blow | Alliance |
| 28.08.2025 07:00 | SVNS | Solvonis secures exclusive CNS collaboration | RNS |
| 13.08.2025 15:03 | SVNS | Media Coverage: Small Cap Idea profile | Reach |
| 12.08.2025 18:32 | SVNS | Solvonis shares jumps as touts positive results at PTSD therapy trials | Alliance |
| 12.08.2025 11:17 | SVNS, XAR, SUS | SMALL-CAP WINNERS & LOSERS: S&U hails motor finance verdict; Xaar down | Alliance |
| 12.08.2025 07:00 | SVNS | SVN-SDN-14 PTSD - Positive pre-clinical results | RNS |
| 31.07.2025 16:30 | SVNS | Total Voting Rights | RNS |
| 22.07.2025 07:00 | SVNS | Translational Bridging Studies | RNS |
| 18.07.2025 11:03 | SVNS | Exercise of warrants | RNS |
| 14.07.2025 07:00 | SVNS | Solvonis Chair to speak at Lucid Capital Markets | Reach |
| 11.07.2025 10:35 | CAR, SVNS, ASLI | SMALL-CAP WINNERS & LOSERS: Solvonis raises GBP1 million at premium | Alliance |
| 11.07.2025 10:07 | SVNS | Solvonis Therapeutics raises GBP1.0 million for drug discovery scheme | Alliance |
| 11.07.2025 07:00 | SVNS | £1m subscription to accelerate AI drug discovery | RNS |
| 08.07.2025 07:00 | SVNS | Holding(s) in Company | RNS |
| 27.06.2025 14:38 | SVNS | AGM Statement | RNS |
| 27.06.2025 08:54 | SVNS | Holding(s) in Company | RNS |
| 26.06.2025 10:21 | SVNS | Initiation of Research Coverage | Reach |
| 23.06.2025 11:12 | SVNS | Solvonis granted US patent for AI-led CNS compound programme | Alliance |
| 23.06.2025 07:00 | SVNS | Allowance of U.S. patent covering AI-supported CNS | RNS |
| 20.06.2025 12:02 | TEK, SUN, RKH | UK shareholder meetings calendar - next 7 days | Alliance |
| 11.06.2025 22:13 | SVNS, BMS, AVAP | TRADING UPDATES: Ten Lifestyle celebrates new Japan contract win | Alliance |
| 11.06.2025 07:30 | SVNS | Initiation of AI supported CNS drug discovery | RNS |
| 05.06.2025 07:00 | SVNS | Synthesis of development candidate for SVN-SDN-014 | RNS |
| 03.06.2025 16:30 | SVNS | Notice of Annual General Meeting | RNS |
| 03.06.2025 14:02 | SVNS | Solvonis promotes Professor David Nutt to chief scientific officer | Alliance |
| 03.06.2025 07:00 | SVNS | Appointment of Prof. David Nutt as CSO | RNS |
| 02.06.2025 11:58 | SVNS | Holding(s) in Company | RNS |
| 30.05.2025 17:00 | SVNS | Total Voting Rights | RNS |
| 29.05.2025 15:11 | SVNS | Holding(s) in Company | RNS |
| 29.05.2025 12:02 | SVNS | Holding(s) in Company | RNS |
| 29.05.2025 10:30 | SVNS | Holding(s) in Company | RNS |
| 29.05.2025 07:00 | SVNS | Presentation at Mello2025 | Reach |
| 28.05.2025 07:30 | SVNS | Holding(s) in Company | RNS |
| 28.05.2025 07:00 | SVNS | Completion of the acquisition of Awakn | RNS |
| 21.05.2025 15:24 | SVNS | Publication of a Prospectus | RNS |
| 16.05.2025 21:51 | WBI, GUN, SVNS | TRADING UPDATES: T42 IOT Tracking extends CLN repayment dates | Alliance |
| 16.05.2025 07:31 | SVNS | Result of placing | RNS |
| 15.05.2025 16:53 | SVNS | Proposed equity fundraising via ABB | RNS |
| 28.04.2025 11:30 | SVNS | Result of General Meeting | RNS |
| 23.04.2025 07:00 | SVNS | Proposed acquisition of Awakn approved | RNS |
| 22.04.2025 16:58 | RWA, OCDO, NXQ | UK shareholder meetings calendar - next 7 days | Alliance |
| 16.04.2025 14:05 | SVNS | Solvonis shares fall with "high risk" that losses will continue | Alliance |
| 16.04.2025 07:00 | SVNS | Final Results for the year ended 31 December 2024 | RNS |
| 10.04.2025 14:00 | SVNS | Posting of Circular and Notice of General Meeting | RNS |
| 07.04.2025 07:00 | SVNS | Holding(s) in Company | RNS |
| 04.04.2025 21:44 | KGH, ENQ, SQZ | TRADING UPDATES: Knights Group seals buy; Kanabo position uncertain | Alliance |
| 04.04.2025 07:00 | SVNS | Engagement of PharmaVentures | RNS |
| 26.03.2025 13:43 | SVNS | Solvonis reports positive progress on European patent for Awakn collab | Alliance |
| 26.03.2025 07:00 | SVNS | Positive progress on European Patent Application | RNS |
| 18.03.2025 07:00 | SVNS | Update on AWKN-SDN-14 programme | RNS |
| 11.03.2025 09:00 | SVNS | Holding(s) in Company | RNS |
| 11.03.2025 07:00 | SVNS | Appointment of Non-Executive Director | RNS |
| 25.02.2025 07:00 | SVNS | Presentation at PharmaSynergyRx Event | Reach |
| 24.02.2025 12:23 | SVNS | Solvonis to buy Awakn Life Sciences for around GBP5 million | Alliance |
| 24.02.2025 07:00 | SVNS | Entry into an Arrangement Agreement with Awakn | RNS |
| 30.01.2025 12:00 | SVNS | Proactive Investors interview with Chairman | Reach |
| 27.01.2025 07:00 | SVNS | Update on Awakn Life Sciences’ R&D Progress | RNS |
| 24.01.2025 07:00 | SVNS | Investor Presentation | Reach |
| 21.01.2025 14:29 | SVNS | Proactive Investors interview with CEO | Reach |
| 21.01.2025 07:00 | SVNS | Update on FDA Pre-IND Meeting for Awakn | RNS |
| 15.01.2025 07:00 | SVNS | Interview with CEO | Reach |
